# OnCo record moonlight-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/moonlight-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "moonlight-bio" ;
  schema:name "Moonlight Bio"@en ;
  schema:alternateName "Moonlight Bio, Inc"@en ;
  schema:description "Moonlight Bio makes CAR-T cell therapy for solid tumours, adding gene changes found naturally in human T cells to make the treated cells multiply and last longer. Its first product, ML261, targets DLL3 and is in an early trial for small cell lung cancer and related neuroendocrine cancers."@en ;
  schema:url <https://onco.cc/companies/moonlight-bio/>, <https://moonlightbio.us/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://moonlightbio.us/>, <https://moonlightbio.us/our-science>, <https://clinicaltrials.gov/study/NCT07488923> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/prostate-nepc/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/armored-car/> ;
  onco:targets <https://onco.cc/targets/dll3/> .